Skip to main content
. 2021 Mar 10;11:5549. doi: 10.1038/s41598-021-85002-1

Figure 6.

Figure 6

Effect of GPR139 agonist on preference to the neutral compartment during fear memory recall. (A) Representative top-view video tracking of swimming behaviour in controls (a and c, 0.2% and 2% DMSO, respectively) and the fish treated with GPR139 agonist (b and d, 0.1 and 1 µg/g BW of JNJ-63533054, respectively). (B) Total time spent in the neutral context (grey compartment) during post-conditioning in controls and GPR139 agonist-treated fish. The fish treated with 0.1 µg/g BW of GPR139 agonist spent a significantly (P = 0.0477) longer time in the neutral compartment as compared to control. *, P < 0.05. n.s., no significant difference.